Correction: An investigation into the impact and implications of published papers from retracted research: Systematic search of affected literature (BMJ Open (2019) 9 (e031909) DOI: 10.1136/bmjopen-2019-031909);An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature

BMJ Open

Volumn 9, Issue 10, 2019, Pages

  Avenell, Alison ^a   Stewart, Fiona ^a   Grey, Andrew ^b   Gamble, Greg ^b   Bolland, Mark ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

hip fractures; impact; randomised controlled trials; scientific misconduct

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); EVIDENCE BASED PRACTICE; HIP FRACTURE; HUMAN; META ANALYSIS (TOPIC); NARRATIVE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PUBLICATION; SCIENTIFIC MISCONDUCT; SELECTION BIAS; SYSTEMATIC REVIEW (TOPIC); JOURNAL IMPACT FACTOR; PUBLISHING;

CLINICAL TRIALS AS TOPIC; HIP FRACTURES; HUMANS; JOURNAL IMPACT FACTOR; RETRACTION OF PUBLICATION AS TOPIC; SCIENTIFIC MISCONDUCT;

EID: 85074339361     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2019-031909corr1     Document Type: Erratum

References (95)

1. Bolland MJ, Avenell A, Gamble GD, et al. Systematic review and statistical analysis of the integrity of 33 randomized controlled trials. Neurology 2016;87:2391-402.
2. Gross RA, Editor-in-Chief. Statistics and the detection of scientific misconduct. Neurology 2016;87:2388.
3. Steen RG. Retractions in the medical literature: how can patients be protected from risk? J Med Ethics 2012;38:228-32.
4. Marcus A. A scientist's fraudulent studies put patients at risk. Science 2018;362:394.
5. Davis PM. The persistence of error: a study of retracted articles on the Internet and in personal libraries. J Med Libr Assoc 2012;100:184-9.
6. Sato Y, Maruoka H, Oizumi K. Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation. Stroke 1997;28:736-9.
7. Sato Y, Honda Y, Kuno H, et al. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D-and K-deficient stroke patients. Bone 1998;23:291-6.
8. Sato Y, Manabe S, Kuno H, et al. Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:64-8.
9. Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002;31:114-8.
10. Sato Y, Kanoko T, Satoh K, et al. Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone 2005;36:61-8.
11. Sato Y, Iwamoto J, Kanoko T, et al. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005;64:811-6.
12. Sato Y, Iwamoto J, Kanoko T, et al. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 2005;165:1743-8.
13. Sato Y, Kanoko T, Satoh K, et al. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med 2005;165:1737-42.
14. Sato Y, Honda Y, Iwamoto J, et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2005;293:1082-8.
15. Sato Y, Iwamoto J, Kanoko T, et al. Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. Mov Disord 2006;21:924-9.
16. Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology 2007;68:911-5.
17. Sato Y, Iwamoto J, Honda Y. Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2011;82:1390-3.
18. Cockayne S, Adamson J, Lanham-New S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:1256-61.
19. Torgerson DJ. Caution to readers about systematic review on vitamin K and prevention of fractures that included problematic trials. JAMA Intern Med 2018;178:863-4.
20. Caution of conclusions of a meta-analysis including problematic trials. JAMA Intern Med 2018;178:875-6.
21. Zhang W, Zhu C, Sun M, et al. Efficacy of bisphosphonates against hip fracture in elderly patients with stroke and Parkinson diseases: meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis 2014;23:2714-24.
22. Zhao Y, Shen L, Ji H-F. Alzheimer's disease and risk of hip fracture: a meta-analysis study. ScientificWorldJournal 2012;2012:1-5.
23. Orimo H, Nakamura T, Hosoi T, et al. Japanese 2011 guidelines for prevention and treatment of osteoporosis-executive summary. Arch Osteoporos 2012;7:3-20.
24. Dai Z, Koh W-P. B-vitamins and bone health-a review of the current evidence. Nutrients 2015;7:3322-46.
25. Richy F, Ethgen O, Bruyere O, et al. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 2004;15:301-10.
26. Richy F, Schacht E, Bruyere O, et al. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcif Tissue Int 2005;76:176-86.
27. Murad MH, Drake MT, Mullan RJ, et al. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab 2012;97:1871-80.
28. Yang J, Hu X, Zhang Q, et al. Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone 2012;51:376-82.
29. McCarus DC. Fracture prevention in postmenopausal osteoporosis: a review of treatment options. Obstet Gynecol Surv 2006;61:39-50.
30. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012;85.
31. Batchelor F, Hill K, Mackintosh S, et al. What works in falls prevention after stroke?: a systematic review and meta-analysis. Stroke 2010;41:1715-22.
32. Herrmann M, Peter Schmidt J, Umanskaya N, et al. The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 2007;45:1621-32.
33. Peterson AL. A review of vitamin D and Parkinson's disease. Maturitas 2014;78:40-4.
34. Binks S, Dobson R. Risk factors, epidemiology and treatment strategies for metabolic bone disease in patients with neurological disease. Curr Osteoporos Rep 2016;14:199-210.
35. Alibhai SMH, Gogov S, Allibhai Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 2006;60:201-15.
36. Carda S, Cisari C, Invernizzi M, et al. Osteoporosis after stroke: a review of the causes and potential treatments. Cerebrovasc Dis 2009;28:191-200.
37. Simpson JSA, Crawford SG, Goldstein ET, et al. Systematic review of safety and tolerability of a complex micronutrient formula used in mental health. BMC Psychiatry 2011;11:62.
38. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014;84.
39. Lv Z, Qi H, Wang L, et al. Vitamin D status and Parkinson's disease: a systematic review and meta-analysis. Neurol Sci 2014;35:1723-30.
40. Marsden J, Gibson LM, Lightbody CE, et al. Can early onset bone loss be effectively managed in post-stroke patients? an integrative review of the evidence. Age Ageing 2008;37:142-50.
41. Rucklidge JJ, Kaplan BJ. Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother 2013;13:49-73.
42. Salari P, Larijani B, Abdollahi M. Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 2008;5:215-22.
43. Zhao Y, Sun Y, Ji H-F, et al. Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis. Nutrition 2013;29:828-32.
44. Avenell A, Mak JCS, O'Connell D, et al. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014;39(4).
45. Cameron ID, Gillespie LD, Robertson MC, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 2012;67.
46. Latham NK, Anderson CS, Reid IR. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc 2003;51:1219-26.
47. Verheyden GSAF, Weerdesteyn V, Pickering RM, et al. Interventions for preventing falls in people after stroke. Cochrane Database Syst Rev 2013;26.
48. Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006;119:777-85.
49. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart Association/American stroke association. Stroke 2014;45:2160-236.
50. Healthcare Improvement Scotland. SIGN 142. management of osteoporosis and the prevention of fragility fractures. Scottish Intercollegiate guidelines network: Edinburgh; 2015.
51. MacLean C, Alexander A, Carter J. Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Comparative effectiveness review number 12. Rockville, MA Agency for Healthcare Research and Quality; 2007. et al.
52. MacLean C, Newberry S, Maglione M, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 2008;148:197-213.
53. Qaseem A, Snow V, Shekelle P, et al. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of physicians. Ann Intern Med 2008;149:404-15.
54. Crandall CJ, Newberry SJ, Diamant A, et al. Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 report. Rockville, MA Agency for Healthcare Research and Quality; 2012.
55. Qaseem A, Forciea MA, McLean RM, et al. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of physicians. Ann Intern Med 2017;166:818-39.
56. Currie L. Fall and Injury Prevention. In: Patient safety and quality: an evidence-based handbook for nurses [Internet. Rockville, MD: Agency for Healthcare Research and Quality, 2008.
57. Michael YL, Lin JS, Whitlock EP, et al. Interventions to prevent falls in older adults. An updated systematic review. Evidence syntheses. Rockville, MA Agency for Healthcare Research and Quality; 2010.
58. Bauman WA, Spungen AM, Morrison N, et al. Effect of a vitamin D analog on leg bone mineral density in patients with chronic spinal cord injury. JRRD 2005;42:625-33.
59. Berendsen A, Santoro A, Pini E, et al. A parallel randomized trial on the effect of a healthful diet on inflammageing and its consequences in European elderly people: design of the NU-AGE dietary intervention study. Mech Ageing Dev 2013;134:523-30.
60. Binkley N, Harke J, Krueger D, et al. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res 2009;24:983-91.
61. Emaus N, Nguyen ND, Almaas B, et al. Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women. Eur J Nutr 2013;52:49-55.
62. Grieger JA, Nowson CA, Jarman HF, et al. Multivitamin supplementation improves nutritional status and bone quality in aged care residents. Eur J Clin Nutr 2009;63:558-65.
63. Herrmann M, Umanskaya N, Traber L, et al. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin Chem Lab Med 2007;45:1785-92.
64. Rucklidge JJ, Andridge R, Gorman B, et al. Shaken but unstirred? effects of micronutrients on stress and trauma after an earthquake: RCT evidence comparing formulas and doses. Hum Psychopharmacol 2012;27:440-54.
65. van Wijngaarden JP, Swart KMA, Enneman AW, et al. Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial. Am J Clin Nutr 2014;100:1578-86.
66. Agrawal S, Krueger DC, Engelke JA, et al. Between-meal risedronate does not alter bone turnover in nursing home residents. J Am Geriatr Soc 2006;54:790-5.
67. Gommans J, Yi Q, Eikelboom JW, et al. The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. BMC Geriatr 2013;13:88.
68. Green TJ, McMahon JA, Skeaff CM, et al. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr 2007;85:460-4.
69. Sawka AM, Ray JG, Yi Q, et al. Randomized clinical trial of homocysteine level-lowering therapy and fractures. Arch Intern Med 2007;167:2136-9.
70. Booth SL, Dallal G, Shea MK, et al. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008;93:1217-23.
71. Emaus N, Gjesdal CG, Almas B, et al. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int 2010;21:1731-40.
72. Herrmann W, Kirsch SH, Kruse V, et al. One year B and D vitamins supplementation improves metabolic bone markers. Clin Chem Lab Med 2013;51:639-47.
73. Shiraki M, Itabashi A. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study. J Bone Miner Metab 2009;27:333-40.
74. Marret E, Elia N, Dahl JB, et al. Susceptibility to fraud in systematic reviews: lessons from the Reuben case. Anesthesiology 2009;111:1279-89.
75. Moore RA, Derry S, McQuay HJ. Fraud or flawed: adverse impact of fabricated or poor quality research. Anaesthesia 2010;65:327-30.
76. Sox HC, Rennie D. Research misconduct, retraction, and cleansing the medical literature: lessons from the Poehlman case. Ann Intern Med 2006;144:609-13.
77. Retraction Watch. What should you do if a paper you've cited is later retracted? Available: http://retractionwatch. com/2016/11/01/whatshould-you-do-if-a-paper-youve-cited-is-later-retracted/[Accessed 23 Nov 2018]
78. Barbour V, Bloom T, Lin J, et al. Amending published articles: time to rethink retractions and corrections? F1000Research 1960;2017.
79. Habib AS, Gan TJ. Scientific fraud: impact of Fujii's data on our current knowledge and practice for the management of postoperative nausea and vomiting. Anesth Analg 2013;116:520-2.
80. Wiedermann CJ. Inaction over retractions of identified fraudulent publications: ongoing weakness in the system of scientific self-correction. Account Res 2018;25:239-53.
81. Bornemann-Cimenti H, Szilagyi IS, Sandner-Kiesling A. Perpetuation of retracted publications using the example of the Scott S. Reuben case: incidences, reasons and possible improvements. Sci Eng Ethics 2016;22:1063-72.
82. Bar-Ilan J, Halevi G. Temporal characteristics of retracted articles. Scientometrics 2018;116:1771-83.
83. Mott A, Fairhurst C, Torgerson D. Assessing the impact of retraction on the citation of randomized controlled trial reports: an interrupted time-series analysis. J Health Serv Res Policy 2019;24:44-51.
84. White PF, Kehlet H, Liu S. Perioperative analgesia: what do we still know? Anesth Analg 2009;108:1364-7.
85. Clarke CE. Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:510-1.
86. Poole KES, Warburton EA, Reeve J. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005;65:1513-4.
87. Caffrey N, Casey M, Walsh B. Substandard studies or substandard "standard-of-care". J Bone Miner Res 2006;21:491.
88. Halbekath JM, Schenk S, von Maxen A, et al. Risedronate for the prevention of hip fractures: concern about validity of trials. Arch Intern Med 2007;167:513-4.
89. Gotzsche PC, Hrobjartsson A, Mari? K, et al. Data extraction errors in meta-analyses that use standardized mean differences. JAMA 2007;298:430-7.
90. Mistry V, Grey A, Bolland MJ. Publication rates after the first retraction for biomedical researchers with multiple retracted publications. Account Res 2019;26:277-87.
91. van der Vet PE, Nijveen H. Propagation of errors in citation networks: a study involving the entire citation network of a widely cited paper published in, and later retracted from Nature. Res Integr Peer Rev 2016;1.
92. Fanelli D, Moher D. What difference do retractions make? an estimate of the epistemic impact of retractions on recent meta-analyses. bioRxiv 2019.
93. Elia N, Wager E, Tramèr MR. Fate of articles that warranted retraction due to ethical concerns: a descriptive cross-sectional study. PLoS One 2014;9:e85846.
94. Zotero. Retracted item notifications with retraction Watch integration. Available: https://www. zotero. org/ blog/ retracted-item-notifications/ [Accessed 7 Aug 2019].
95. Cheng YY, Parulian N, Hsiao TK, et al. ReTracker: actively and automatically matching retraction metadata in Zotero. 82nd Annual Meeting of the Association for Information Science & Technology, Melbourne, Australia, 2019. Available: http:// jodischneider. com/ pubs/ asist2019retracker. pdf [Accessed 07 Aug 2019].